Since Cirrhosis can progress to Hepatocellular Carcinoma, studies have suggested that the combined measurement of Alpha-Fetoprotein and IL-17 levels in peripheral serum can predict the prognosis of cirrhotic patients (60). The gene discussed is IL17A; the disease is Cirrhosis.